SBFM Return on Tangible Equity | Sunshine Biopharma Inc.

Sunshine Biopharma Inc. (SBFM) Return on Tangible Equity

2026-06-30: Return Tang Equity -22.70%.
2026-03-31: Return Tang Equity -30.82%.
2025-12-31: Return Tang Equity -28.25%.
2025-09-30: Return Tang Equity -27.01%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-22.70%
2026-03-31	-30.82%
2025-12-31	-28.25%
2025-09-30	-27.01%
2025-06-30	-27.19%
2025-03-31	-25.78%
2024-12-31	-25.07%
2024-09-30	-19.12%
2024-06-30	-17.49%
2024-03-31	-17.96%
2023-12-31	-22.80%
2023-09-30	-129.02%
2023-06-30	-126.04%
2023-03-31	-151.29%
2022-12-31	-128.27%
2022-09-30	-6.35%
2022-06-30	-12.29%
2022-03-31	-56.24%
2021-12-31	-5875.62%
2021-09-30	771.21%
2021-06-30	705.05%
2021-03-31	507.12%
2020-12-31	171.80%
2020-09-30	171.80%
2020-06-30	140.68%
2020-03-31	112.93%
2019-12-31	118.50%
2019-09-30	113.76%
2019-06-30	145.72%
2019-03-31	238.53%
2018-12-31	298.86%
2018-09-30	322.58%
2018-06-30	133.61%
2018-03-31	94.54%
2017-12-31	181.43%
2017-09-30	551.97%
2017-06-30	550.27%
2017-03-31	1297.52%
2016-12-31	1667.47%
2016-09-30	1032.81%
2016-06-30	150.69%
2016-03-31	172.43%
2015-12-31	137.15%
2015-09-30	405.01%
2015-06-30	537.64%
2015-03-31	726.35%
2014-12-31	485.41%
2014-09-30	808.14%
2014-06-30	629.95%
2014-03-31	1340.67%
2013-12-31	32347.38%
2013-09-30	-4153.85%
2013-06-30	-1502.52%
2013-03-31	-906.92%
2012-12-31	-1005.24%
2012-09-30	-352.01%
2012-06-30	-792.64%
2012-03-31	-855.03%
2011-12-31	-538.05%
2011-09-30	188.28%
2010-12-31	-1242.75%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-28.25%
2024-12-31	-25.07%
2023-12-31	-22.80%
2022-12-31	-128.27%
2021-12-31	-5875.62%
2020-12-31	171.80%
2019-12-31	118.50%
2018-12-31	298.86%
2017-12-31	181.43%
2016-12-31	1667.47%
2015-12-31	136.37%
2014-12-31	499.05%
2013-12-31	32314.95%
2012-12-31	-1005.24%
2011-12-31	-539.99%
2010-12-31	-273.87%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Aptevo Therapeutics Inc. (APVO)	United States	$0.003B
Alaunos Therapeutics, Inc. (TCRT)	United States	$0.003B	-1.44
Genprex, Inc. (GNPX)	United States	$0.003B	-0.02
Silo Pharma, Inc. (SILO)	United States	$0.003B	-1.57
Onconetix, Inc. (ONCO)	United States	$0.004B
GeoVax Labs, Inc. (GOVX)	United States	$0.003B	-0.45
Petros Pharmaceuticals, Inc. (PTPI)	United States	$0.003B
HCW Biologics Inc. (HCWB)	United States	$0.004B	-6.15
REVELATION BIOSCIENCES, INC. (REVB)	United States	$0.004B
Matinas BioPharma Holdings, Inc. (MTNB)	United States	$0.003B